Author: Takeshi Kobayashi
Publisher: Springer Science & Business Media
ISBN: 9783540204084
Category : Technology & Engineering
Languages : en
Pages : 240
Book Description
The areas we deal with in biochemical engineering have expanded to include many various organisms and humans. This book has gathered together the information of these expanded areas in biochemical engineering in Japan. These two volumes are composed of 15 chapters on microbial cultivation techniques, metabolic engineering, recombinant protein production by transgenic avian cells to biomedical engineering including tissue engineering and cancer therapy. Hopefully, these volumes will give readers a glimpse of the past and also a view of what may happen in biochemical engineering in Japan.
Recent Progress of Biochemical and Biomedical Engineering in Japan I
Author: Takeshi Kobayashi
Publisher: Springer Science & Business Media
ISBN: 9783540204084
Category : Technology & Engineering
Languages : en
Pages : 240
Book Description
The areas we deal with in biochemical engineering have expanded to include many various organisms and humans. This book has gathered together the information of these expanded areas in biochemical engineering in Japan. These two volumes are composed of 15 chapters on microbial cultivation techniques, metabolic engineering, recombinant protein production by transgenic avian cells to biomedical engineering including tissue engineering and cancer therapy. Hopefully, these volumes will give readers a glimpse of the past and also a view of what may happen in biochemical engineering in Japan.
Publisher: Springer Science & Business Media
ISBN: 9783540204084
Category : Technology & Engineering
Languages : en
Pages : 240
Book Description
The areas we deal with in biochemical engineering have expanded to include many various organisms and humans. This book has gathered together the information of these expanded areas in biochemical engineering in Japan. These two volumes are composed of 15 chapters on microbial cultivation techniques, metabolic engineering, recombinant protein production by transgenic avian cells to biomedical engineering including tissue engineering and cancer therapy. Hopefully, these volumes will give readers a glimpse of the past and also a view of what may happen in biochemical engineering in Japan.
Recent Progress of Biochemical and Biomedical Engineering in Japan II
Author: Takeshi Kobayashi
Publisher: Springer Science & Business Media
ISBN: 9783540204190
Category : Technology & Engineering
Languages : en
Pages : 264
Book Description
The areas we deal with in biochemical engineering have expanded to include many various organisms and humans. This book has gathered together the information of these expanded areas in biochemical engineering in Japan. These two volumes are composed of 15 chapters on microbial cultivation techniques, metabolic engineering, recombinant protein production by transgenic avian cells to biomedical engineering including tissue engineering and cancer therapy. Hopefully, these volumes will give readers a glimpse of the past and also a view of what may happen in biochemical engineering in Japan.
Publisher: Springer Science & Business Media
ISBN: 9783540204190
Category : Technology & Engineering
Languages : en
Pages : 264
Book Description
The areas we deal with in biochemical engineering have expanded to include many various organisms and humans. This book has gathered together the information of these expanded areas in biochemical engineering in Japan. These two volumes are composed of 15 chapters on microbial cultivation techniques, metabolic engineering, recombinant protein production by transgenic avian cells to biomedical engineering including tissue engineering and cancer therapy. Hopefully, these volumes will give readers a glimpse of the past and also a view of what may happen in biochemical engineering in Japan.
Recent Progress of Biochemical and Biomedical Engineering in Japan
Author:
Publisher:
ISBN:
Category : Biochemical engineering
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Biochemical engineering
Languages : en
Pages :
Book Description
Biomanufacturing
Author: Jian-Jiang Zhong
Publisher: Springer Science & Business Media
ISBN: 9783540205012
Category : Medical
Languages : en
Pages : 352
Book Description
With contributions by numerous experts
Publisher: Springer Science & Business Media
ISBN: 9783540205012
Category : Medical
Languages : en
Pages : 352
Book Description
With contributions by numerous experts
Tissue Engineering I
Author: Kyongbum Lee
Publisher: Springer
ISBN: 3540319484
Category : Technology & Engineering
Languages : en
Pages : 253
Book Description
This book covers trends in modern biotechnology. All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from Chemistry, Biochemistry, Microbiology, Genetics, Chemical Engineering and Computer Science, are treated. More information as well as the electronic version available at springeronline.com
Publisher: Springer
ISBN: 3540319484
Category : Technology & Engineering
Languages : en
Pages : 253
Book Description
This book covers trends in modern biotechnology. All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from Chemistry, Biochemistry, Microbiology, Genetics, Chemical Engineering and Computer Science, are treated. More information as well as the electronic version available at springeronline.com
Analytics of Protein-DNA Interactions
Author: Harald Seitz
Publisher: Springer Science & Business Media
ISBN: 3540481478
Category : Medical
Languages : en
Pages : 212
Book Description
With contributions by numerous experts
Publisher: Springer Science & Business Media
ISBN: 3540481478
Category : Medical
Languages : en
Pages : 212
Book Description
With contributions by numerous experts
Microbial Energy Conversion
Author: Zhenhong Yuan
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 311042486X
Category : Technology & Engineering
Languages : en
Pages : 568
Book Description
The book provides an overview on various microorganisms and their industrialization in energy conversion, such as ethanol fermentation, butanol fermentation, biogas fermentation and fossil energy conversion. It also covers microbial oil production, hydrogen production and electricity generation. The content is up to date and suits well for both researchers and industrial audiences.
Publisher: Walter de Gruyter GmbH & Co KG
ISBN: 311042486X
Category : Technology & Engineering
Languages : en
Pages : 568
Book Description
The book provides an overview on various microorganisms and their industrialization in energy conversion, such as ethanol fermentation, butanol fermentation, biogas fermentation and fossil energy conversion. It also covers microbial oil production, hydrogen production and electricity generation. The content is up to date and suits well for both researchers and industrial audiences.
White Biotechnology
Author: Roland Ulber
Publisher: Springer Science & Business Media
ISBN: 3540456953
Category : Science
Languages : en
Pages : 309
Book Description
With contributions by numerous experts
Publisher: Springer Science & Business Media
ISBN: 3540456953
Category : Science
Languages : en
Pages : 309
Book Description
With contributions by numerous experts
Sterile Filtration
Author: Maik W. Jornitz
Publisher: Springer
ISBN: 3540330186
Category : Science
Languages : en
Pages : 211
Book Description
Publisher: Springer
ISBN: 3540330186
Category : Science
Languages : en
Pages : 211
Book Description
Cell Culture Engineering
Author: Wei-Shu Hu
Publisher: Springer
ISBN: 3540340076
Category : Science
Languages : en
Pages : 179
Book Description
Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.
Publisher: Springer
ISBN: 3540340076
Category : Science
Languages : en
Pages : 179
Book Description
Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.